#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15432	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2079	737.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	896	C	836	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27208	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3383	801.2	0	.	n	.	0	A20C	SNP	20	20	A	250	250	C	521	C,A	490,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27208	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3383	801.2	0	.	n	.	0	T695C	SNP	695	695	T	925	925	C	821	C	767	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27208	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3383	801.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1868	1868	G	913	G,A	856,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27208	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3383	801.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2201	2201	C	890	C,T	822,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27208	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3383	801.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2275	2275	A	879	A	829	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27208	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3383	801.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2827	2827	C	868	C	805	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2132	folP	855	855	100.0	folP.l15.c4.ctg.1	1564	135.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1081	1083	AGC	225;221;218	A,G;G;C,T	214,1;212;205,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5490	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3480	157.3	1	SNP	p	S91F	1	.	.	271	273	TTC	596	598	TTC	182;181;182	T;T;C	170;168;169	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5490	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3480	157.3	1	SNP	p	G95N	0	.	.	283	285	GGC	608	610	GGC	176;180;179	G;G;C	164;164;165	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5490	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3480	157.3	1	SNP	p	D95G	1	.	.	283	285	GGC	608	610	GGC	176;180;179	G;G;C	164;164;165	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1678	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1369	121.9	0	.	p	.	0	F184L	NONSYN	550	552	TTC	849	851	TTG	181;179;184	T;T;G	172;167;174	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1678	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1369	121.9	1	SNP	p	G45D	0	.	.	133	135	GGC	432	434	GGC	241;237;232	G;G;C	218;216;213	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	854	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1065	79.6	0	.	n	.	0	A197.	DEL	197	197	A	536	536	A	204	A	187	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5144	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	170.7	1	SNP	p	D86N	0	.	.	256	258	GAC	579	581	GAC	214;211;210	G;A;C	204;200;203	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5144	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	170.7	1	SNP	p	R87W	0	.	.	259	261	CGT	582	584	CGT	210;208;204	C;G;T	204;202;198	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5144	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	170.7	1	SNP	p	S87R	1	.	.	259	261	CGT	582	584	CGT	210;208;204	C;G;T	204;202;198	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5144	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	170.7	1	SNP	p	R87I	0	.	.	259	261	CGT	582	584	CGT	210;208;204	C;G;T	204;202;198	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5144	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3001	170.7	1	SNP	p	S88P	0	.	.	262	264	TCC	585	587	TCC	207;206;207	T;C;C,A,T	199;199;197,1,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4336	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2751	157.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1585	1587	GGC	227;228;224	G;G;C	213;216;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1185	1187	GCA	217;218;220	G;C;A	204;206;209	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1188	1190	ATC	221;222;225	A;T;C	209;211;212	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1200	1202	GTG	232;233;230	G;T;G	214;214;213	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1200	1202	GTG	232;233;230	G;T;G	214;214;213	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1704	1706	ACC	219;220;220	A;C;C	200;205;206	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1758	1760	GCG	201;199;201	G;C;G	174;165;174	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1758	1760	GCG	201;199;201	G;C;G	174;165;174	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1881	1883	AGC	187;185;186	A;G;C	171;169;169	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1890	1892	GGC	184;181;180	G;G;C	165;160;159	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4170	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	172.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1908	1910	CCG	183;184;180	C,G,T;C;G	136,4,2;144;142	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5732	ponA	2397	2397	99.92	ponA.l15.c30.ctg.1	2997	189.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1685	1687	CTG	211;214;212	C;T;G	187;195;190	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2196	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1864	117.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	529	529	C	172	C	159	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	402	404	GAA	213;215;217	G;A;A	204;207;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	813	815	TCA	252;256;257	T;C;A	228;236;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	942	944	GTC	236;236;237	G,T;T;C,A	218,1;220;222,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	954	956	TCT	233;225;229	T;C;T	217;212;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1272	1274	GCA	213;211;211	G;C;A	205;199;201	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	245;243;243	A;A;G	235;231;229	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	1	SNP	p	D121N	0	.	.	361	363	GAC	651	653	GAC	246;249;250	G;A;C	233;233;235	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2824	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1479	189.2	1	SNP	p	A121D	1	.	.	361	363	GAC	651	653	GAC	246;249;250	G;A;C	233;233;235	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10344	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4867	211.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1114	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	996	111.1	1	SNP	p	V57M	1	.	.	169	171	ATG	446	448	ATG	252;251;248	A;T;G	234;233;230	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
